<DOC>
	<DOCNO>NCT01962155</DOCNO>
	<brief_summary>The aim prospective study construct validate non-invasive model consist biochemical marker , FibroScan , radiological parameter evaluate liver fibrosis cause hepatitis B virus mainland China .</brief_summary>
	<brief_title>Prospective Stuy Evaluating Hepatic Fibrosis Related Hepatitis B Virus Using Non-invasive Parameters</brief_title>
	<detailed_description>Up Oct , 2015 , total 1800 patient chronic HBV infection enrol . Paired blood liver biopsy sample collect . Blood sample store -80 degree Celsius . Liver biopsy sample judge three pathology expert .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>1 . HBsAg positive least 6 month 2. agree liver biopsy 3 . Male female age 18 65 year old 1 . Patients alcoholic liver disease , autoimmune liver disease , heretic liver disease , drug induce liver disease , nonalcoholic liver disease chronic liver disease 2. platelet count &lt; 80000/L 3. prothrombin activity â‰¤ 60 % 4. patient disease condition investigator treat physician feel would interfere trial safety subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Fibrosis</keyword>
	<keyword>Liver Cirrhosis</keyword>
	<keyword>non-invasive</keyword>
	<keyword>biopsy</keyword>
	<keyword>hepatitis B virus</keyword>
</DOC>